Re-stimulation of lymphocytes ex vivo with gB498-505 peptide demonstrated an increase in the number of endogenous gB-specific CD8+ T cells in the spleen, tumor and lymph nodes of mice vaccinated with IFNα1 or IFNβ compared to vaccination alone (Figure 3A). This evidence concerns the gene CD8A and neoplasm.